Cargando…

Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination

A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP).

Detalles Bibliográficos
Autor principal: Zargaran, Massoumeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307884/
https://www.ncbi.nlm.nih.gov/pubmed/35898746
http://dx.doi.org/10.1002/ccr3.6126
_version_ 1784752860743860224
author Zargaran, Massoumeh
author_facet Zargaran, Massoumeh
author_sort Zargaran, Massoumeh
collection PubMed
description A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP).
format Online
Article
Text
id pubmed-9307884
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93078842022-07-26 Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination Zargaran, Massoumeh Clin Case Rep Editorial A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP). John Wiley and Sons Inc. 2022-07-22 /pmc/articles/PMC9307884/ /pubmed/35898746 http://dx.doi.org/10.1002/ccr3.6126 Text en © 2022 The Author. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Zargaran, Massoumeh
Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination
title Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination
title_full Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination
title_fullStr Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination
title_full_unstemmed Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination
title_short Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination
title_sort suggested risk factor for oral lichen planus arising after mrna covid‐19 vaccination
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307884/
https://www.ncbi.nlm.nih.gov/pubmed/35898746
http://dx.doi.org/10.1002/ccr3.6126
work_keys_str_mv AT zargaranmassoumeh suggestedriskfactorfororallichenplanusarisingaftermrnacovid19vaccination